Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance MechanismsPeter W. Szlosarek, Michael Sheaff|JTO Clinical and Research Reports|2020Cited by 30